首页 >
法规速递
-
Page: Paediatric-use marketing authorisations-2025/7/31
2025-08-01查看详情 > -
Document: List of changes to combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animal and humans to veterinary medicinal products for 2025-2025/7/31
2025-08-01查看详情 > -
Page: EudraVigilance: electronic reporting-2025/7/31
2025-08-01查看详情 > -
Document: List of changes to combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animal and humans to veterinary medicinal products for 2025-2025/7/30
2025-07-31查看详情 > -
Page: EudraVigilance: electronic reporting-2025/7/30
2025-07-31查看详情 > -
Page: Cholic acid product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Dabrafenib product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Search tips-2025/7/30
2025-07-31查看详情 > -
Page: Azacitidine product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Document: Overview of comments received on the “HMA/EMA guidance document on the identification of personal data and commercially confidential information within the structure of the marketing authorisation application (MAA) dossier” - public consultation
2025-07-31查看详情 >
